Validation and verification framework and data integration of biosensors and in vitro diagnostic devices: a position statement of the IFCC Committee on Mobile Health and Bioengineering in Laboratory Medicine (C-MBHLM) and the IFCC Scientific Division

Author:

Gruson Damien123,Cobbaert Christa45,Dabla Pradeep Kumar63,Stankovic Sanja783,Homsak Evgenija93,Kotani Kazuhiko103,Samir Assaad Ramy11123ORCID,Nichols James H.133,Gouget Bernard3ORCID

Affiliation:

1. Department of Clinical Biochemistry , Cliniques Universitaires St-Luc and Université Catholique de Louvain , Brussels , Belgium

2. Pôle de recherche en Endocrinologie, Diabète et Nutrition, Institut de Recherche Expérimentale et Clinique , Cliniques Universitaires St-Luc and Université Catholique de Louvain , Brussels , Belgium

3. Emerging Technologies Division and MHBLM Committee, International Federation Clinical Chemistry and Laboratory Medicine (IFCC) , Milan , Italy

4. Department of Clinical Chemistry and Laboratory Medicine , Leiden University Medical Centre (LUMC) , Leiden , Netherlands

5. International Federation of Clinical Chemistry (IFCC) Scientific Division , Milan , Italy

6. Department of Biochemistry , G.B. Pant Institute of Postgraduate Medical Education & Research, Associated Maulana Azad Medical College , New Delhi , India

7. Center for Medical Biochemistry , University Clinical Center of Serbia , Belgrade , Serbia

8. Faculty of Medical Sciences , University of Kragujevac , Kragujevac , Serbia

9. Department for Laboratory Diagnostics , University Clinical Center Maribor , Maribor , Slovenia

10. Division of Community and Family Medicine , Jichi Medical University , Shimotsuke-City , Japan

11. Medical Research Institute - Alexandria University , Alexandria , Egypt

12. Egyptian Association of Healthcare Quality and Patient Safety , Alexandria , Egypt

13. Department of Pathology, Microbiology and Immunology , Vanderbilt University Medical Center , Nashville , TN , USA

Abstract

Abstract Advances in technology have transformed healthcare and laboratory medicine. Biosensors have emerged as a promising technology in healthcare, providing a way to monitor human physiological parameters in a continuous, real-time, and non-intrusive manner and offering value and benefits in a wide range of applications. This position statement aims to present the current situation around biosensors, their perspectives and importantly the need to set the framework for their validation and safe use. The development of a qualification framework for biosensors should be conceptually adopted and extended to cover digitally measured biomarkers from biosensors for advancing healthcare and achieving more individualized patient management and better patient outcome.

Publisher

Walter de Gruyter GmbH

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Six years of progress – highlights from the IFCC Emerging Technologies Division;Clinical Chemistry and Laboratory Medicine (CCLM);2024-08-14

2. Principles of Interoperability of Diabetes Devices;Journal of Diabetes Science and Technology;2024-08-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3